GE HealthCare Technologies Inc. (LON:0ADL)

Market Cap	24.07B
Revenue (ttm)	14.57B
Net Income (ttm)	1.63B
Shares Out	n/a
EPS (ttm)	3.56
PE Ratio	14.72
Forward PE	15.42
Dividend	0.05 (0.07%)
Ex-Dividend Date	Jul 25, 2025

Volume	578
Average Volume	2,809
Open	70.16
Previous Close	72.28
Day's Range	70.16 - 70.16
52-Week Range	64.49 - 92.38
Beta	n/a
RSI	40.53
Earnings Date	Jul 30, 2025

About Revance Therapeutics

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided ther...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2022
• Employees: 53,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0ADL

Financial Performance

In 2024, LON:0ADL's revenue was $19.67 billion, an increase of 0.61% compared to the previous year's $19.55 billion. Earnings were $1.99 billion, an increase of 43.90%.